Devyser Diagnostics AB publishes Interim Report for the period, January to September 2022
"Devyser reports yet another quarter of record sales and strong gross margins. The positive sales and margin trend remains stable. We are following the strategic plan we launched nearly two years ago. It involves converting to direct sales in certain markets where we are currently working with distributors, and increasing our focus on selected key markets, including the important North American market. So far, we have managed to exceed the plan’s high expectations on sales growth and margins.” Fredrik Alpsten, CEO, Devyser Quarter July-September 2022 · Net sales amounted to